Tag Archives: Alzheimer’s

How Aduhelm, an Unproven Alzheimer’s Drug, Got Approved

Advertisement Continue reading the main story Supported by Continue reading the main story How an Unproven Alzheimer’s Drug Got Approved Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab. The F.D.A. conducted an internal inquiry this year after allegations were… Read More »

Signaling molecule may prevent Alzheimer’s

New research in humans and mice identifies a particular signaling molecule that can help modify inflammation and the immune system to protect against Alzheimer’s disease. The work, which was led by investigators at Harvard-affiliated Massachusetts General Hospital (MGH), is published in Nature. Cognitive decline associated with Alzheimer’s disease develops when neurons begin to die. “Neuron death… Read More »

In Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug

Advertisement Continue reading the main story Supported by Continue reading the main story In Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug The agency faced criticism for approving Aduhelm for all Alzheimer’s patients. Now it recommends that the drug be given only to those with mild symptoms. A patient received an infusion of… Read More »